Anthrax toxin-neutralizing antibody reconfigures the protective antigen heptamer into a supercomplex.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 20660775.
- Also identified by DOI 10.1073/pnas.1006473107 and PMC identifier 2922573.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The tripartite protein exotoxin secreted by Bacillus anthracis, a major contributor to its virulence and anthrax pathogenesis, consists of binary complexes of the protective antigen (PA) heptamer (PA63h), produced by proteolytic cleavage of PA, together with either lethal factor or edema factor. The mouse monoclonal anti-PA antibody 1G3 was previously shown to be a potent antidote that shares F(C) domain dependency with the human monoclonal antibody MDX-1303 currently under clinical development. Here we demonstrate that 1G3 instigates severe perturbation of the PA63h structure and creates a PA supercomplex as visualized by electron microscopy. This phenotype, produced by the unconventional mode of antibody action, highlights the feasibility for optimization of vaccines based on analogous structural modification of PA63h as an additional strategy for future remedies against anthrax.
Medical subject headings
- Antibodies, Neutralizing
- Antigen-Antibody Complex
- Antigens, Bacterial
- Bacterial Toxins